Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus : a phase II randomised controlled trial. CommentaryCAHN, Pedro; SUED, Omar; HARVEY, Charlotte M et al.Lancet (British edition). 2007, Vol 369, Num 9569, issn 0140-6736, 1235-1236,1261-1269 [11 p.]Article

A mobile trauma database with charge captureMOULTON, Steve; MYUNG, Dan; CHARY, Aron et al.The Journal of trauma, injury, infection, and critical care. 2005, Vol 59, Num 5, pp 1042-1047, issn 1079-6061, 6 p.Conference Paper

Lack of a Significant Drug Interaction between Raltegravir and TenofovirWENNING, Larissa A; FRIEDMAN, Evan J; STONE, Julie A et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 9, pp 3253-3258, issn 0066-4804, 6 p.Article

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 InfectionCOOPER, David A; STEIGBIGEL, Roy T; SCHECHTER, Mauro et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 355-365, issn 0028-4793, 11 p.Article

Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled TrialLE, Thuy-Anh; CHEN, Joshua; CHANGCHIEN, Christopher et al.Hepatology (Baltimore, Md.). 2012, Vol 56, Num 3, pp 922-932, issn 0270-9139, 11 p.Article

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phaseMURRAY, John M; EMERY, Sean; KELLEHER, Anthony D et al.AIDS (London). 2007, Vol 21, Num 17, pp 2315-2321, issn 0269-9370, 7 p.Article

Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionSTEIGBIGEL, Roy T; COOPER, David A; KATLAMA, Christine et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 339-354, issn 0028-4793, 16 p.Article

Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapySAAH, Alfred J; HAAS, David W; CONDRA, Jon H et al.The Journal of infectious diseases. 2003, Vol 187, Num 7, pp 1157-1162, issn 0022-1899, 6 p.Article

Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infectionHIRSCH, Martin S; STEIGBIGEL, Roy T; LEAVITT, Randi Y et al.Clinical infectious diseases. 2003, Vol 37, Num 8, pp 1119-1124, issn 1058-4838, 6 p.Article